Physicochemical stability of compounded midazolam capsules over a one-year storage period
In patients suffering from chronic liver disease, the hepatic metabolism of drugs is perturbed and the metabolic capacity is difficult to assess. Midazolam could be used as a phenotypical probe to predict the metabolic capacity of CYP3A to adjust dosages of drug substrates of this cytochrome. In thi...
Saved in:
Main Authors: | Boivin Pierre-Nicolas (Author), Legendre Pauline (Author), Bonnaure Anne-Claire (Author), Lester Marie-Antoinette (Author) |
---|---|
Format: | Book |
Published: |
De Gruyter,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Physicochemical Stability of 5 mg/mL Pediatric Prednisone Oral Suspension in Syrspend® SF PH4
by: Bonnaure Anne-Claire, et al.
Published: (2018) -
Physicochemical stability of 20 mg/mL amiodarone hydrochloride oral suspension in SyrSpend® SF PH4 (liquid)
by: Adoum Anissa, et al.
Published: (2022) -
Stability of 5 mg/mL Nitrendipine Oral Suspension in Syrspend® SF PH4
by: Bellay Romain, et al.
Published: (2018) -
Midazolam and haloperidol for palliative sedation: physicochemical stability and compatibility of parenteral admixtures
by: Gabriel Estan-Cerezo, et al. -
Physicochemical Stability of Mozobil® (Plerixafor) Solution for Injection in Glass Vials and Plastic Syringes over a Three-Month Storage Period
by: Kim Sun Hee, et al.
Published: (2016)